Cutting Edge Information

Generic drug sales to exceed $60 billion by 2007

Published in Biotech Law Weekly, August 20th, 2004

Industry-wide generic drug sales are expected to exceed $60 billion by 2007, according to a report published by pharmaceutical research firm, Cutting Edge Information.

This growth corresponds with an increase in branded prescription drugs losing patent protection in coming years. As generics pose a significant threat to branded drugs, pharmaceutical companies are preparing to defend their drugs.

Sanofi has recently developed Ambien CR, a new time-released version of its blockbuster Ambien sleeping drug, according to a Pharmaceutical Business Review article. Upon successful approval, Ambien CR could reach the market by 2005, allowing Sanofi...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Law Weekly

Source: Biotech Law Weekly (2004-08-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry